- Optimal dose determination from the PAC203 study expected in mid-2019 with topline data expected in the third quarter of 2019 -
PR Newswire
SEATTLE, Dec. 28, 2018
PR Newswire
SEATTLE, Dec. 28, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey